Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Prehabilitation Group Deuterated Water

PreclinicalBiologic

UUniversidad de La Frontera

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Total Hip ReplacementNot yet recruiting

Total Hip ReplacementPreclinical

Not yet recruiting

Timeline

Expected Milestones

Q1 2029

N/ANot yet recruiting

Total Hip Replacement

NCT07048080

Clinical

Trials by Indication[1]

Total Hip Replacement1 trial

Prehabilitation in Older People Undergoing Total Hip Replacement

Not yet recruiting·UUniversidad de La Frontera·N/A·NCT07048080·70 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Prehabilitation Group Deuterated Water. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prehabilitation Group Deuterated Water compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prehabilitation Group Deuterated Water. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Universidad de La Frontera company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: UUniversidad de La Frontera

Related News